University of Applied Sciences, HU, Utrecht, The Netherlands.
Leiden University Medical Centre, Leiden, The Netherlands.
ALTEX. 2024 Jan 9;41(1):69-75. doi: 10.14573/altex.2304161. Epub 2023 Aug 8.
While the original definition of replacement focuses on the replacement of the use of animals in science, a more contemporary definition focuses on accelerating the development and use of predictive and robust models, based on the latest science and technologies, to address scientific questions without the use of animals. The transition to animal free innovation is on the political agenda in and outside the European Union. The Beyond Animal Testing Index (BATI) is a benchmarking instrument designed to provide insight into the activities and contributions of research institutes to the transition to animal free innovation. The BATI allows participating organizations to learn from each other and stimulates continuous improvement. The BATI was modelled after the Access to Medicine Index, which benchmarks pharmaceutical companies on their efforts to make medicines widely available in developing countries. A prototype of the BATI was field-tested with three Dutch academic medical centers and two universities in 2020-2021. The field test demonstrated the usability and effectiveness of the BATI as a benchmarking tool. Analyses were performed across five different domains. The participating institutes concluded that the BATI served as an internal as well as an external stimulus to share, learn, and improve institutional strategies towards the transition to animal free innovation. The BATI also identified gaps in the development and implementation of 3R technologies. Hence, the BATI might be a suitable instrument for monitoring the effectiveness of policies. BATI version 1.0 is ready to be used for benchmarking at a larger scale.
虽然替代的最初定义侧重于在科学中替代动物的使用,但更现代的定义侧重于基于最新的科学和技术,加速开发和使用预测性和稳健的模型,以解决没有使用动物的科学问题。在欧盟内外,向无动物创新的转变已提上政治议程。无动物测试指标 (BATI) 是一种基准工具,旨在深入了解研究机构为向无动物创新过渡所做的活动和贡献。BATI 允许参与组织相互学习,并激发持续改进。BATI 是根据衡量制药公司在发展中国家广泛提供药物的努力的药物获取指数模型设计的。BATI 的原型于 2020 年至 2021 年在三个荷兰学术医疗中心和两所大学进行了实地测试。实地测试证明了 BATI 作为基准工具的可用性和有效性。对五个不同领域进行了分析。参与的机构得出结论,BATI 既是内部的也是外部的刺激因素,可以分享、学习和改进机构向无动物创新过渡的策略。BATI 还确定了 3R 技术的开发和实施方面的差距。因此,BATI 可能是监测政策有效性的合适工具。BATI 1.0 版已准备好大规模用于基准测试。